caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1073515201

Mark JacobsM.D.

Obstetrics & GynecologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

CCN 450358
Hospital
CCN 450674
Hospital
CCN 450709
Hospital
REFERRAL NETWORK

Where Mark Jacobs's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
CHCA WOMANS HOSPITAL LP1749
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
1730
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Houston, TX
132178
Laboratory Corporation Of America
Clinical Laboratory · San Antonio, TX
82106
Stephen Cone
Obstetrics & Gynecology · Houston, TX
5688
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
1730
Laboratory Corporation Of America Holdings
Clinical Laboratory · Burlington, NC
1223
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
231
Unique beneficiaries
—
Total services
265
Distinct HCPCS
4
Medicare payment
$17K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,532 Obstetrics & Gynecology providers in TX — top quintile (cohort median 92).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
688
Beneficiaries
—
Total drug cost
$88K
Distinct drugs
14
Brand share
43.5%
Top prescribed drugs
Estradiol224 claims
Estrogens, Conjugated80 claims
Raloxifene Hcl66 claims
Estrogen,con/M-Progest Acet39 claims
Alendronate Sodium37 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$39
Payment records
2
By payment type
Food and Beverage$39